131 related articles for article (PubMed ID: 31494160)
41. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.
Ayumi NS; Sahudin S; Hussain Z; Hussain M; Samah NHA
Drug Deliv Transl Res; 2019 Apr; 9(2):482-496. PubMed ID: 29569027
[TBL] [Abstract][Full Text] [Related]
42. Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline.
Rawal T; Patel S; Butani S
Eur J Pharm Sci; 2018 Nov; 124():273-287. PubMed ID: 30176365
[TBL] [Abstract][Full Text] [Related]
43. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
Tam YT; To KK; Chow AH
Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
[TBL] [Abstract][Full Text] [Related]
44. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
Ahmed TA; El-Say KM
Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393
[TBL] [Abstract][Full Text] [Related]
45. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
Brar V; Kaur G
Pharm Nanotechnol; 2018; 6(3):180-191. PubMed ID: 30101724
[TBL] [Abstract][Full Text] [Related]
46. Preparation, characterization and in vitro release study of β-cyclodextrin/chitosan nanoparticles loaded Cinnamomum zeylanicum essential oil.
Matshetshe KI; Parani S; Manki SM; Oluwafemi OS
Int J Biol Macromol; 2018 Oct; 118(Pt A):676-682. PubMed ID: 29959997
[TBL] [Abstract][Full Text] [Related]
47. Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.
Adena SKR; Upadhyay M; Vardhan H; Mishra B
Drug Dev Ind Pharm; 2018 Mar; 44(3):493-501. PubMed ID: 29161920
[TBL] [Abstract][Full Text] [Related]
48. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
[TBL] [Abstract][Full Text] [Related]
49. Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab.
Savin CL; Popa M; Delaite C; Costuleanu M; Costin D; Peptu CA
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():843-860. PubMed ID: 30813091
[TBL] [Abstract][Full Text] [Related]
50. Collagen/chitosan film containing biotinylated glycol chitosan nanoparticles for localized drug delivery.
Chen MM; Huang YQ; Cao H; Liu Y; Guo H; Chen LS; Wang JH; Zhang QQ
Colloids Surf B Biointerfaces; 2015 Apr; 128():339-346. PubMed ID: 25784300
[TBL] [Abstract][Full Text] [Related]
51. Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.
Yu X; Hou J; Shi Y; Su C; Zhao L
Int J Nanomedicine; 2016; 11():6035-6046. PubMed ID: 27881917
[TBL] [Abstract][Full Text] [Related]
52. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
Shahbazi MA; Hamidi M; Mohammadi-Samani S
J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
[TBL] [Abstract][Full Text] [Related]
53. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
Shah B; Khunt D; Misra M; Padh H
Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
[TBL] [Abstract][Full Text] [Related]
54. Development of drug delivery systems for taxanes using ionic gelation of carboxyacyl derivatives of chitosan.
Skorik YA; Golyshev AA; Kritchenkov AS; Gasilova ER; Poshina DN; Sivaram AJ; Jayakumar R
Carbohydr Polym; 2017 Apr; 162():49-55. PubMed ID: 28224894
[TBL] [Abstract][Full Text] [Related]
55. pH responsive biodegradable nanogels for sustained release of bleomycin.
Sahu P; Kashaw SK; Kushwah V; Sau S; Jain S; Iyer AK
Bioorg Med Chem; 2017 Sep; 25(17):4595-4613. PubMed ID: 28734664
[TBL] [Abstract][Full Text] [Related]
56. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
57. Application of Box-Behnken experimental design for the formulation and optimisation of selenomethionine-loaded chitosan nanoparticles coated with zein for oral delivery.
Vozza G; Danish M; Byrne HJ; Frías JM; Ryan SM
Int J Pharm; 2018 Nov; 551(1-2):257-269. PubMed ID: 30153488
[TBL] [Abstract][Full Text] [Related]
58. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
Jafarieh O; Md S; Ali M; Baboota S; Sahni JK; Kumari B; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2015; 41(10):1674-81. PubMed ID: 25496439
[TBL] [Abstract][Full Text] [Related]
59. Manipulation of pH-Sensitive interactions between podophyllotoxin-chitosan for enhanced controlled drug release.
Chen C; Yu Y; Wang X; Shi P; Wang Y; Wang P
Int J Biol Macromol; 2017 Feb; 95():451-461. PubMed ID: 27867056
[TBL] [Abstract][Full Text] [Related]
60. Artemisinin loaded chitosan magnetic nanoparticles for the efficient targeting to the breast cancer.
Natesan S; Ponnusamy C; Sugumaran A; Chelladurai S; Shanmugam Palaniappan S; Palanichamy R
Int J Biol Macromol; 2017 Nov; 104(Pt B):1853-1859. PubMed ID: 28359890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
